The Access to Medicine Index is a comprehensive database of major pharmaceutical companies' efforts to help improve access to affordable essential drugs in developing countries. By bringing transparency to the industry, the index aims to further engage private investors and the pharmaceutical companies and, in doing so, to encourage collaboration with other stakeholders.

Research for the index draws on numerous sources and rates the data against dozens of carefully chosen criteria. Companies themselves were invited to verify data accuracy, and independent world experts reviewed a draft research report. This first edition of the index demonstrates clearly that there are large differences within the pharmaceutical industry as a whole.

• WHO Pushes Pharmaceutical Innovation (Briefings)
• Reward Pharmaceutical Innovators in Proportion to the Health Impact of Their Invention (Innovations)
• The Determinants of Pharmaceutical Research and Development Investments (Policy Library)
• Preserving PEPFAR (Briefings)
• Prizes, Not Patents (Commentary)
• Merck's Dubai Ethics Center (Innovations)
• Patent Absurdity (Briefings)
• Human Rights Challenges Facing Abbott Laboratories: Risks and Recommendations (Policy Library)
• The International AIDS Vaccine Initiative Story (Innovations)
• Patents, Compulsory License and Access to Medicines: Some Recent Experiences (Policy Library)
• Intellectual Property Rights and Access to Essential Medicines (Policy Library)